Press Releases from MD Stem Cells (3 total)
New treatment shows vision benefit in Age Related Macular Degeneration
MD Stem Cells reports dry AMD results from their clinical study SCOTS- the Stem Cell Ophthalmology Treatment Study. 63% of treated and evaluated eyes achieved improvement in vision while an additional 34% had vision remain stable in follow up. No complications occurred.
==============================================================================
Age Related Macular Degeneration- specifically dry AMD- will affect almost 200 million people world-wide in 2020. An approach, pioneered by MD Stem Cells, using bone marrow stem…
Stem Cells in new spinal cord paraplegia study showing improvements
MD Stem Cells reports initial results of their new study in paraplegia using Bone Marrow Derived Stem Cells (BMSC) have shown a prompt improvement in sensory function. The Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality (SciExVR) study is an Institutional Review Board approved, patient sponsored clinical study registered with the National Institutes of Health (NIH) NCT 03225625. It uses a multi-injection and application approach of…
Dr. Steven Levy, CEO of MD Stem Cells, joins editorial board of Clinical Trials …
MD Stem Cells announces that the company’s President and CEO, Steven Levy MD, has joined the editorial board of Clinical Trials in Degenerative Diseases (CTDD). In addition to his role as executive officer for MD Stem Cells, Dr. Levy is Study Director for several pivotal stem cell clinical trials using autologous bone marrow derived stem cells. These including SCOTS –the Stem Cell Ophthalmology Treatment Study (NCT 0192086) ,…
